The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via sp1 to promote proliferation of breast cancer cells

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 927-935

  Yue, Lin ^a   Li, Leilei ^a   Liu, Fangfang ^b   Hu, Nan ^a   Zhang, Weiying ^a   Bai, Xiao ^a   Li, Yinghui ^a   Zhang, Yingyi ^a   Fu, Li ^b   Zhang, Xiaodong ^a   Ye, Lihong ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN D1; CYCLIN E; HEPATITIS B VIRUS X PROTEIN; LIM 4 PROTEIN; LIM PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; CYCLIN E; DISEASE PROGRESSION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84875921629     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs399     Document Type: Article

References (42)

1. et al. (1998) Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J. Virol., 72, 1737-1743.
2. Adams,R.R. et al. (2001) Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol., 11, 49-54.
3. Zangemeister-Wittke,U. et al. (2004) An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle, 3, 1121-1123.
4. Minczuk,M. et al. (2005) Human ATP-dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIP. FEBS J., 272, 5008-5019.
5. Fujii,R. et al. (2006) HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res., 66, 9099-9107.
6. Wen,Y. et al. (2008) Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J. Biol. Chem., 283, 2793-2803.
7. Wang,F.Z. et al. (2008) Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells. Acta Pharmacol. Sin., 29, 83-89.
8. Wang,F.Z. et al. (2007) Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol. Sin., 28, 431-438.
9. Liu,S. et al. (2012) The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. J. Biol. Chem; 287, 30228-39.
10. Yu,J. et al. (2008) LIM only 4 is overexpressed in late stage pancreas cancer. Mol. Cancer, 7, 93.
11. Sum,E.Y. et al. (2005) Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc. Natl. Acad. Sci. U.S.A., 102, 7659-7664.
12. Singh,R.R. et al. (2005) Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res., 65, 10594-10601.
13. Kashani,A.H. et al. (2006) Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections. J. Neurosci., 26, 8398-8408.
14. Murphy,N.C. et al. (2008) Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br. J. Cancer, 98, 537-541.
15. Mousses,S. et al. (2002) Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res., 62, 1256-1260.
16. Wang,N. et al. (2007) The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene, 26, 6431-6441.
17. Tian,Y. et al. (2010) Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells. Clin. Exp. Metastasis, 27, 455-463.
18. Montañez-Wiscovich,M.E. et al. (2010) Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. J. Pathol., 222, 271-281.
19. Resnitzky,D. et al. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.
20. Lee,R.J. et al. (2000) Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell. Biol., 20, 672-683.
21. Montañez-Wiscovich,M.E. et al. (2009) LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene, 28, 3608-3618.
22. Ye,L.H. et al. (2006) Screening of a sub-clone of human breast cancer cells with high metastasis potential. Zhonghua Yi Xue Za Zhi, 86, 61-65.
23. Hu,N. et al. (2011) miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J. Biol. Chem., 286, 13714-13722.
24. Lu,Z. et al. (2006) LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells. Oncogene, 25, 2920-2930.
25. Lu,S. et al. (2010) Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int. J. Cancer, 126, 416-425.
26. Liu,B.Y. et al. (2012) Mammary tumor regression elicited by Wnt signaling inhibitor requires IGFBP5. Cancer Res., 72, 1568-1578.
27. Wittlin,S. et al. (2003) Two promoters within the human LMO4 gene contribute to its overexpression in breast cancer cells. Genomics, 82, 280-287.
28. Shan,C. et al. (2010) Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res., 20, 563-575.
29. Wang,W. et al. (2012) MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis, 33, 1113-1120.
30. Dif,N. et al. (2006) Insulin activates human sterol-regulatory-elementbinding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem. J., 400, 179-188.
31. Furuta,E. et al. (2008) Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res., 68, 1003-1011.
32. Jung,J.K. et al. (2007) Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res., 67, 5771-5778.
33. Kong,G. et al. (2011) Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS ONE, 6, e19518.
34. Deeb,D. et al. (2011) Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis, 32, 757-764.
35. Chen,L. et al. (2009) Cross-regulation of the Nanog and Cdx2 promoters. Cell Res., 19, 1052-1061.
36. Wang,Y. et al. (2009) LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell, 138, 660-672.
37. Zhang,X. et al. (2005) Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J. Med. Virol., 77, 374-381.
38. Garcia-Saez,I. et al. (2011) Structural characterization of HBXIP: the protein that interacts with the anti-apoptotic protein survivin and the oncogenic viral protein HBx. J. Mol. Biol., 405, 331-340.
39. Marusawa,H. et al. (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J., 22, 2729-2740.
40. Ben-Shachar,D. et al. (2007) Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS ONE, 2, e817.
41. Li,L. et al. (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat., 192, 275-283.
42. Safe,S. et al. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer, 41, 2438-2448.